Menopause Flashcards

1
Q

average age

A

51

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the contraception advice in terms of how long?

A

12 months after the last period in women > 50 years

24 months after the last period in women < 50 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mx (x3)

A

Lifestyle modifications
Hormone replacement therapy (HRT)
Non-hormone replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mx life style

A

hot flushes - exercise, weight loss and reduced stress

sleep - avoid late evening exercise and maintain good sleep hygiene

mood - sleep, reg exercise and relax

cognitive - reg exercise and sleep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

contraindications to hrt

A

Current or past breast cancer
Any oestrogen-sensitive cancer
Undiagnosed vaginal bleeding
Untreated endometrial hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what form of hrt can be given

A

oral or transdermal patch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

how long can symptoms menopause last for

A

2-5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

risk of hrt

A

VTE

Stroke

CHD

Breast Ca

Ovarian Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

management of vasomotor symptoms non-hrt

A

fluoxetine, citalopram or venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

vaginal dryness management

A

Vaginal lubricant or moisturiser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

psychological symptoms

A

self-help groups, cognitive behaviour therapy or antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

urogenital symptoms

A

urogenital atrophy vaginal oestrogen - if they are not taking hrt this is appropriate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

stopping treatment

A

For vasomotor symptoms, 2-5 years of HRT may be required with regular attempts made to discontinue treatment. Vaginal oestrogen may be required long term. When stopping HRT it is important to tell women that gradually reducing HRT is effective at limiting recurrence only in the short term. In the long term, there is no difference in symptom control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

stopping treatment

A

For vasomotor symptoms, 2-5 years of HRT may be required with regular attempts made to discontinue treatment. Vaginal oestrogen may be required long term. When stopping HRT it is important to tell women that gradually reducing HRT is effective at limiting recurrence only in the short term. In the long term, there is no difference in symptom control.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

when should you refer to secondary care

A

She should be referred to secondary care if treatment has been ineffective, if there are ongoing side effects or if there is unexplained bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

symptoms

A

Change in periods
change in length of menstrual cycles
dysfunctional uterine bleeding may occur

Vasomotor symptoms - affects around 80% of women. Usually occur daily and may continue for up to 5 years
hot flushes
night sweats

Urogenital changes - affects around 35% of women
vaginal dryness and atrophy
urinary frequency

Psychological
anxiety and depression may be seen - around 10% of women
short-term memory impairment

Longer term complications
osteoporosis
increased risk of ischaemic heart disease

16
Q

symptoms

A

Change in periods
change in length of menstrual cycles
dysfunctional uterine bleeding may occur

Vasomotor symptoms - affects around 80% of women. Usually occur daily and may continue for up to 5 years
hot flushes
night sweats

Urogenital changes - affects around 35% of women
vaginal dryness and atrophy
urinary frequency

Psychological
anxiety and depression may be seen - around 10% of women
short-term memory impairment

Longer term complications
osteoporosis
increased risk of ischaemic heart disease